biotech · Major Depressive Disorder · Schizophrenia · NBIX
NEUROCRINE BIOSCIENCES
NEUROCRINE BIOSCIENCES INC
NEUROCRINE BIOSCIENCES clinical programs — 23 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 6027 Edgewood Bend Ct, San Diego, California 92130, US
- Founded
- 1992
- Employees
- 2,307
- Programs
- 79
- Drugs
- 28
- Patents
- 111
NEUROCRINE BIOSCIENCES projects
23 ClinicalTrials.gov programs sponsored by NEUROCRINE BIOSCIENCES.
NEUROCRINE BIOSCIENCES has 23 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Chronocort®
NEUROCRINE BIOSCIENCES INC
Congenital Adrenal Hyperplasia
5 trials -
Crinecerfont
NEUROCRINE BIOSCIENCES INC
Congenital Adrenal Hyperplasia
4 trials -
Hydrocortisone
NEUROCRINE BIOSCIENCES INC
Congenital Adrenal Hyperplasia
2 trials -
Indiplon
NEUROCRINE BIOSCIENCES INC
Insomnia
1 trial -
Infacort®
NEUROCRINE BIOSCIENCES INC
Adrenal Insufficiency
4 trials -
NBI-1065845
NEUROCRINE BIOSCIENCES INC
Major Depressive Disorder
1 trial -
NBI-1065845
NEUROCRINE BIOSCIENCES INC
Major Depressive Disorder
5 trials -
NBI-1065845-MDD3024
NEUROCRINE BIOSCIENCES INC
Major Depressive Disorder
1 trial -
NBI-1065845-MDD3025
NEUROCRINE BIOSCIENCES INC
Major Depressive Disorder
1 trial -
NBI-1065845-MDD3026
NEUROCRINE BIOSCIENCES INC
Major Depressive Disorder
1 trial -
NBI-1065845-MDD3027
NEUROCRINE BIOSCIENCES INC
Major Depressive Disorder
1 trial -
NBI-1117568
NEUROCRINE BIOSCIENCES INC
Schizophrenia
5 trials -
NBI-1117568, NBI-1117568
NEUROCRINE BIOSCIENCES INC
Schizophrenia, Schizophrenia
1 trial -
NBI-1117568-SCZ3030
NEUROCRINE BIOSCIENCES INC
Schizophrenia
1 trial -
NBI-34060
NEUROCRINE BIOSCIENCES INC
Insomnia
1 trial -
NBI-74788-CAH2006
NEUROCRINE BIOSCIENCES INC
Classic Congenital Adrenal Hyperplasia (CAH)
1 trial -
NBI-74788-CAH3003
NEUROCRINE BIOSCIENCES INC
Classic Congenital Adrenal Hyperplasia (CAH)
1 trial -
NBI-98854
NEUROCRINE BIOSCIENCES INC
Tardive Dyskinesia
6 trials -
NBI-98854-ATS3019
NEUROCRINE BIOSCIENCES INC
Schizophrenia
1 trial -
Placebo
NEUROCRINE BIOSCIENCES INC
Schizophrenia
2 trials -
Placebo
NEUROCRINE BIOSCIENCES INC
Dyskinesia
1 trial -
Valbenazine
NEUROCRINE BIOSCIENCES INC
Chorea, Huntington
3 trials -
Valbenazine
NEUROCRINE BIOSCIENCES INC
Tardive Dyskinesia
2 trials
Frequently asked questions
How many clinical projects does NEUROCRINE BIOSCIENCES have?
23 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.